Company Filing History:
Years Active: 2011-2020
Title: Ruth McAdam: Innovator in Antigen Binding Proteins
Introduction
Ruth McAdam is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of 7 patents to her name, her work has the potential to impact various medical treatments.
Latest Patents
One of her latest patents involves antigen binding proteins that specifically bind to Oncostatin M (OSM). This invention focuses on proteins that inhibit the binding of OSM to the gp130 receptor without directly interacting with site II residues. Additionally, it includes methods for humanizing antibodies and pharmaceutical compositions for medical treatments. Another notable patent concerns nucleic acids encoding immunoglobulins that bind to TGF-beta receptor II. This disclosure provides an anti-TGFbetaRII immunoglobulin single variable domain, which can be used to treat diseases associated with TGFbeta signaling, including tissue fibrosis and rheumatoid arthritis.
Career Highlights
Ruth McAdam is currently employed at Glaxo Group Limited, where she continues to innovate in her field. Her work has garnered attention for its potential applications in treating various diseases, showcasing her expertise and dedication to advancing medical science.
Collaborations
Ruth has collaborated with notable coworkers, including Susannah Karen Ford and Gary Peter Bembridge. These partnerships have contributed to her success and the development of her innovative patents.
Conclusion
Ruth McAdam stands out as a significant figure in the field of biotechnology, with her inventions paving the way for advancements in medical treatments. Her contributions reflect her commitment to innovation and the betterment of healthcare.